- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02394899
Improving Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease
Integrating a Parenting Intervention With Routine Care to Improve Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease
Study Overview
Status
Intervention / Treatment
Detailed Description
Children with sickle cell disease (SCD) are at risk of various complications, many of which arise suddenly and call on the problem solving skills of their parents. They are also at risk of neurocognitive delays; these may become evident during the pre-school years. Previous research by this group has demonstrated improved developmental outcomes after parental interventions incorporating play techniques in high risk and healthy pre-school children. The aim of the study is to determine usefulness in children with SCD of similar developmental interventions augmented by lessons in problem solving.
The study is a randomized controlled trial. Parents of all infants with Hb SS (homozygous sickle cell disease) or Sβ0 -thalassemia disease identified by newborn screening during the initial year of the study will be invited to participate. They will be randomized to intervention or control. Parental stress, infant's development and hemoglobin levels will be measured at recruitment and again after six months. The intervention will occur during monthly Penadur (intramuscular Benzathine Penicillin) visits and will include supervised play with their children using an inexpensive toy and participation in solving a problem which may arise as they parent their child with SCD. At the end of the study, all control dyads will also be given the toys used in the intervention. All parents will be given the results of their children's developmental assessments and appropriate referrals made if deficits are identified.
The study is minimal risk. Every effort will be made to maintain patient confidentiality. Respect for, and the maximum protection of the best interests of the research subjects will be maintained.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kingston 7, Jamaica
- Sickle Cell Unit, University of West Indies, Mona Campus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Infant has sickle cell disease: SS or Sβ0 thalassemia
- Attending Sickle Cell Unit, Jamaica for routine care
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
The control dyad will receive usual care.
|
|
Experimental: Intervened
Parents receive training in problem solving skills and play therapy with their infants.
|
Short films that have been developed to deliver a series of child development messages will be shown at the monthly visits.
Nine modules of approximate length 3 minutes each have been developed and cover the topics: Love, Comforting baby, Talking to babies and children, Praise, Using bath time to play and learn, Looking at books, Simple toys mothers can make, Drawing and games, and Puzzles.
Nurses at the Sickle cell Unit (SCU) will be trained to discuss the video messages with the mothers/caregivers, demonstrate activities they can do with their children and how to make simple toys from household materials.
Mothers/caregivers will practice some of the activities and they will be encouraged to make them part of their daily routine.
Problem solving therapy (PST) aims to empower patients or caregivers in attending to daily challenges.
It is based on cognitive behavioural therapy and can be used in primary care settings.
It encourages persons to use existing resources and skills to function better and find solutions to problems.
It will be delivered in 6 sessions over the 6-week period and will last for about 30 minutes per session.
The stages of PST are: identification of the problems; generating possible solutions; evaluating and implementing preferred solution; and evaluating to see if the solutions were successful.
The parent/caregiver will be taught a process of problem solving with reference to general everyday problems as well as specific problems which may arise while parenting a child with SCD.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Infant's development quotient (Griffiths Developmental Scale)
Time Frame: 6 months
|
Griffiths Developmental Scale
|
6 months
|
Parental stress, depression and coping (Pediatric Inventory for Parents; CES-D; Coping Health Inventory for parents)
Time Frame: 6 months
|
Questionnaires to assess: Pediatric Inventory for Parents; CES-D; Coping Health Inventory for parents
|
6 months
|
Parental problem solving skills (Social Problem Solving Inventory)
Time Frame: 6 months
|
Using Social Problem Solving Inventory: Questionnaires
|
6 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Jennifer Knight-Madden, MBBS, PhD, The University of the West Indies
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0001 (Cancer Research Institute)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sickle Cell Disease
-
Klein Buendel, Inc.National Institute on Minority Health and Health Disparities (NIMHD); Hilton...CompletedSickle Cell Disease | Sickle Cell Anemia in Children | Sickle Cell Thalassemia | Sickle Cell SC DiseaseUnited States
-
Nova Laboratories LimitedCompletedSickle Cell Disease | Sickle Cell Hemoglobin C | Sickle Cell-beta-thalassemia | Sickle-Cell; Hemoglobin Disease, ThalassemiaUnited Kingdom, Jamaica
-
SangartCompletedSickle Cell Disease | Anemia, Sickle Cell | Sickle Cell Anemia | Hemoglobin SC Disease | Sickle Cell Disorders | Sickle Cell Hemoglobin C DiseaseUnited Kingdom, France, Jamaica, Lebanon
-
SangartWithdrawnSickle Cell Disease | Anemia, Sickle Cell | Sickle Cell Anemia | Hemoglobin SC Disease | Sickle Cell Disorders | Sickle Cell Hemoglobin C DiseaseFrance, United Kingdom, Netherlands, Turkey, Bahrain, Belgium, Brazil, Lebanon, Qatar
-
University of British ColumbiaCompletedSickle Cell Disease | Beta-Thalassemia | Sickle Cell Trait | Sickle Cell-Beta Thalassemia | Sickle Cell-SS DiseaseCanada, Nepal
-
Sidney Kimmel Cancer Center at Thomas Jefferson...National Heart, Lung, and Blood Institute (NHLBI)TerminatedSickle Cell Anemia | Sickle Cell-hemoglobin C Disease | Sickle Cell-β0-thalassemiaUnited States
-
University of RegensburgRecruitingSickle Cell Disease | Sickle Cell Anemia | Sickle Cell Disorders | HbS Disease | Hemoglobin S Disease | Sickling Disorder Due to Hemoglobin SGermany, Austria
-
Centre Hospitalier Intercommunal CreteilRecruitingSickle-Cell Disease Nos With CrisisFrance
-
HemaQuest Pharmaceuticals Inc.TerminatedSickle Cell Disease | Sickle Cell Anemia | Sickle Cell Disorders | Hemoglobin S Disease | Sickling Disorder Due to Hemoglobin SUnited States, Lebanon, Egypt, Canada, Jamaica
-
HemaQuest Pharmaceuticals Inc.CompletedSickle Cell Disease | Sickle Cell Anemia | Sickle Cell Disorders | Hemoglobin S Disease | Sickling Disorder Due to Hemoglobin SUnited States, Lebanon, Canada, Egypt, Jamaica
Clinical Trials on Play therapy
-
NORCE Norwegian Research Centre ASUniversity of Bergen; University of ViennaActive, not recruiting
-
Isparta University of Applied SciencesAkdeniz UniversityRecruitingChild | Anxiety | Parents | Preoperative CareTurkey
-
alan apterCompletedNighttime FearsIsrael
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)CompletedAutism Spectrum Disorder | AutismUnited States
-
Alder Hey Children's NHS Foundation TrustWithdrawnPain | Anxiety | RheumatologyUnited Kingdom
-
Kevser PamukCompletedOvarian Cancer | Cervix Cancer | Endometrial Cancer | Grief | Uterine Cancer | Vulva Cancer | FemininityTurkey
-
Hacettepe UniversityCompletedDyslexia | Executive Dysfunction
-
Sehat Medical ComplexRecruitingSpeech, Language Developmental Delay From Hearing LossPakistan
-
University of Southern CaliforniaRecruiting
-
Association for Children at RiskGeha Mental Health CenterTerminatedPost-Traumatic Stress Disorder in ChildrenIsrael